Sienna Cancer Diagnostics Ltd operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sienna Cancer Diagnostics Ltd with three other
pharmaceutical manufacturers in Australasia:
Auscann Group Holdings Ltd
sales of 861,770.00 Australian Dollars [US$513,571.83 ]
MGC Pharmaceuticals Ltd
(858,087.00 Australian Dollars [US$511,376.95 ]
(956,472.00 Australian Dollars [US$570,009.49 ]
During the year ended June of 2019, sales at
Sienna Cancer Diagnostics Ltd were A$1.18 million (US$705.42 thousand).
decrease of 8.6%
versus 2018, when the company's sales were A$1.30 million.